Hitt MM - Search Results

1

Genetic Modifications That Expand Oncolytic Virus Potency.

Cristi F, Gutiérrez T, Hitt MM, Shmulevitz M. Cristi F, et al. Among authors: hitt mm. Front Mol Biosci. 2022 Jan 26;9:831091. doi: 10.3389/fmolb.2022.831091. eCollection 2022. Front Mol Biosci. 2022. PMID: 35155581 Free PMC article. Review.

2

Novel High-throughput Approach for Purification of Infectious Virions.

James KT, Cooney B, Agopsowicz K, Trevors MA, Mohamed A, Stoltz D, Hitt M, Shmulevitz M. James KT, et al. Sci Rep. 2016 Nov 9;6:36826. doi: 10.1038/srep36826. Sci Rep. 2016. PMID: 27827454 Free PMC article.

3

Targeting Nucleotide Biosynthesis: A Strategy for Improving the Oncolytic Potential of DNA Viruses.

Irwin CR, Hitt MM, Evans DH. Irwin CR, et al. Among authors: hitt mm. Front Oncol. 2017 Sep 26;7:229. doi: 10.3389/fonc.2017.00229. eCollection 2017. Front Oncol. 2017. PMID: 29018771 Free PMC article. Review.

4

Breast Tumor-Associated Metalloproteases Restrict Reovirus Oncolysis by Cleaving the σ1 Cell Attachment Protein and Can Be Overcome by Mutation of σ1.

Fernandes JP, Cristi F, Eaton HE, Chen P, Haeflinger S, Bernard I, Hitt MM, Shmulevitz M. Fernandes JP, et al. Among authors: hitt mm. J Virol. 2019 Oct 29;93(22):e01380-19. doi: 10.1128/JVI.01380-19. Print 2019 Nov 15. J Virol. 2019. PMID: 31462562 Free PMC article.

5

Radiation-Induced Cellular Senescence Reduces Susceptibility of Glioblastoma Cells to Oncolytic Vaccinia Virus.

Storozynsky QT, Han X, Komant S, Agopsowicz KC, Potts KG, Gamper AM, Godbout R, Evans DH, Hitt MM. Storozynsky QT, et al. Among authors: hitt mm. Cancers (Basel). 2023 Jun 25;15(13):3341. doi: 10.3390/cancers15133341. Cancers (Basel). 2023. PMID: 37444452 Free PMC article.

6

Oncolytic viruses in the treatment of bladder cancer.

Potts KG, Hitt MM, Moore RB. Potts KG, et al. Among authors: hitt mm. Adv Urol. 2012;2012:404581. doi: 10.1155/2012/404581. Epub 2012 Jul 29. Adv Urol. 2012. PMID: 22899907 Free PMC article.

7

2-aminopurine enhances the oncolytic activity of an E1b-deleted adenovirus in hepatocellular carcinoma cells.

Sharon D, Schümann M, MacLeod S, McPherson R, Chaurasiya S, Shaw A, Hitt MM. Sharon D, et al. Among authors: hitt mm. PLoS One. 2013 Jun 4;8(6):e65222. doi: 10.1371/journal.pone.0065222. Print 2013. PLoS One. 2013. PMID: 23750246 Free PMC article.

8

Myxoma virus oncolytic efficiency can be enhanced through chemical or genetic disruption of the actin cytoskeleton.

Irwin CR, Favis NA, Agopsowicz KC, Hitt MM, Evans DH. Irwin CR, et al. Among authors: hitt mm. PLoS One. 2013 Dec 31;8(12):e84134. doi: 10.1371/journal.pone.0084134. eCollection 2013. PLoS One. 2013. PMID: 24391902 Free PMC article.

9

Deletion of F4L (ribonucleotide reductase) in vaccinia virus produces a selective oncolytic virus and promotes anti-tumor immunity with superior safety in bladder cancer models.

Potts KG, Irwin CR, Favis NA, Pink DB, Vincent KM, Lewis JD, Moore RB, Hitt MM, Evans DH. Potts KG, et al. Among authors: hitt mm. EMBO Mol Med. 2017 May;9(5):638-654. doi: 10.15252/emmm.201607296. EMBO Mol Med. 2017. PMID: 28289079 Free PMC article.

10

Deciphering the Immunomodulatory Capacity of Oncolytic Vaccinia Virus to Enhance the Immune Response to Breast Cancer.

Umer BA, Noyce RS, Franczak BC, Shenouda MM, Kelly RG, Favis NA, Desaulniers M, Baldwin TA, Hitt MM, Evans DH. Umer BA, et al. Among authors: hitt mm. Cancer Immunol Res. 2020 May;8(5):618-631. doi: 10.1158/2326-6066.CIR-19-0703. Epub 2020 Mar 3. Cancer Immunol Res. 2020. PMID: 32127390

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

82 results

Search Page